Validation of the BCLC Prognostic System in Surgical Hepatocellular Cancer Patients

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1260-1263

  Vitale, A ^a   Saracino, E ^b   Boccagni, P ^c   Brolese, A ^c   D'Amico, F ^c   Gringeri, E ^c   Neri, D ^c   Srsen, N ^c   Valmasoni, M ^c   Zanus, G ^c   Carraro, A ^a   Violi, P ^c   Pauletto, A ^c   Bassi, D ^c   Polacco, M ^c   Burra, P ^b   Farinati, F ^b   Feltracco, P ^b   Romano, A ^d   D'Amico, D F ^c   Cillo, U ^c   more..

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; JAPAN; KAPLAN MEIER METHOD; LAPAROSCOPIC SURGERY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; VALIDATION PROCESS; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MIDDLE AGED; PATHOPHYSIOLOGY; VALIDATION STUDY; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 65549111141     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.054     Document Type: Article

References (13)

1. Cillo U., Vitale A., Grigoletto F., et al. Intention-to-treat survival of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transpl 7 (2007) 972
2. Vitale A., Gringeri E., Valmasoni M., et al. Long-term results ofor hepatocellular carcinoma: an update of the university of Padova experience. Transplant Proc 39 (2007) 1892
3. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208
4. Okuda K., Othtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56 (1985) 918
5. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28 (1998) 751
6. UNOS/OPTN policy 3.6.4.4. http://www.optn.org Accessed January 15, 2005
7. Kudo M., Chung H., and Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38 (2003) 207
8. Cillo U., Vitale A., Grigoletto F., et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 44 (2006) 723
9. Chen T.W., Chu C.M., Yu J.C., et al. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. EJSO 33 (2007) 480
10. Cillo U., Bassanello M., Vitale A., et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?. J Hepatol 40 (2004) 124
11. Wang J.H., Changchien C.S., Hu T.H., et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients. Eur J Cancer 44 (2008) 1000
12. Ishizawa T., Hasegawa K., Aoki T., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134 (2008) 1908
13. Minagawa M., Ikai I., Matsuyama Y., et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245 (2007) 909